Daily non-political popular news in brief.

Emerging research heralds new era of breast cancer management

Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review. The review reveals that new approaches in breast cancer imaging, investigations into the timing of chemotherapy and research on breast cancer vaccines may lead to exciting new nonsurgical tools for the physician treating breast cancer patients.

Read more »

Keywords: emerging, research, heralds, era, breast, cancer, management, herald

« Previous | Next »

Similar news on "Emerging research heralds new era of breast cancer management":

1. Sengupta wins $4M breast cancer award
   12-21-2006 · Massachusetts Institute of Technology (MIT)
   Shiladitya Sengupta, assistant professor of medicine at the Harvard-MIT Division of Health Sciences and Technology and Brigham and Women's Hospital, has won one of three 2006 Era of Hope Scholar Awards from the Department of Defense Breast Cancer Research Program.
   Similar news · Read more »
   
2. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
   08-08-2007 · EurekAlert!
   Today Almac Diagnostics announced a major study analyzing ductal carcinoma in situ tissue samples using its novel Breast Cancer DSA microarray. DSA research tools focus on the transcriptome of an individual disease, in this case breast cancer, and contain significant additional data relevant to the disease of interest that is not available on other generic microarrays.
   Similar news · Read more »
   
3. Residual fetal cells in women may provide protection against breast cancer
   10-01-2007 · EurekAlert!
   Fetal cells that persist in a woman's body long after pregnancy -- a common occurrence known in scientific circles as fetal microchimerism -- in some cases may reduce the woman's risk of breast cancer, according to researchers at Fred Hutchinson Cancer Research Center.
   Similar news · Read more »
   
4. Researchers identify unusual molecular switch for common form of advanced breast cancer
   11-08-2007 · EurekAlert!
   New evidence demonstrates that a novel molecular switch is involved in the development of a common form of advanced breast cancer, known as locally advanced breast cancer. The research, published by Cell Press in the Nov. 9, 2007 issue of Molecular Cell, provides an exciting paradigm shift in the understanding of a key event in breast cancer development and presents new therapeutic opportunities for this deadly disease.
   Similar news · Read more »
   
5. Ireland Cancer Center researcher finds standard treatment for breast cancer not followed
   12-21-2007 · EurekAlert!
   Research out of the Ireland Cancer Center of University Hospitals Case Medical Center, in collaboration with six integrated health plans that are part of the Cancer Research Network, found that the majority of older women with early stage breast cancer fail to adhere to the standard of treatment -- five years of daily oral use of the chemo-prevention drug Tamoxifen.
   Similar news · Read more »
   
6. Small RNAs can prevent spread of breast cancer
   01-09-2008 · EurekAlert!
   Howard Hughes Medical Institute researchers have identified small pieces of ribonucleic acid that suppress the spread of breast cancer to the lungs and bone. The new research shows that the most invasive and aggressive human breast cancer tumors are missing three critical microRNA molecules. When the researchers put those molecules back into human breast cancer tumors in mice, the tumors lost their ability to spread.
   Similar news · Read more »
   
7. Breast cancer drug receives FDA approval
   11-17-2006 · EurekAlert!
   Doctor instrumental in research says this is dramatic leap forward in breast cancer treatment.
   Similar news · Read more »
   
8. A black and white look at breast cancer mortality
   02-21-2007 · EurekAlert!
   Researchers suggest a reason for racial disparity in breast cancer survival rates. African and African American women are much less likely to survive breast cancer surgery than their white counterparts and far more likely to get the disease before the menopause. Previous research suggests that those who undergo surgery for the disease before the menopause are more prone to relapse.
   Similar news · Read more »
   
9. Study links breast cancer risk to epigenetic changes related to race, smoking and birth size
   04-15-2007 · EurekAlert!
   Women can encounter environmental factors that increase their risk of breast cancer at various periods of their physical development, beginning before birth and extending until menopause. These non-inherited, or epigenetic, changes in DNA can correlate with risk factors for breast cancer, according to research being presented at the 2007 Annual Meeting of the American Association for Cancer Research.
   Similar news · Read more »
   
10. Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment
    09-18-2007 · EurekAlert!
    Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research.Researchers evaluated 87 women enrolled in the Prevention of Osteoporosis in Postmenopausal Women with Breast Cancer Following Chemotherapy study.
    Similar news · Read more »